Página inicialPodcasts FDA Drug Safety PodcastsFDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)16 de dezembro de 2022FDA Drug Safety PodcastsPlayOuvir episódio
